BLRX
BLRX clinical trials: BioLineRx Ltd.
Every trial on ClinicalTrials.gov where BioLineRx Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 23
- Trials linked
- 18
- As lead sponsor
- 5
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BLRX on the catalyst calendar · BLRX registry changes
- Primary completion Dec 22, 2020ActualPhase 3NCT03246529A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as...BioLineRx, Ltd. · Multiple MyelomaActive, not recruitingBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2022ActualPhase 1NCT05293171Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy SubjectsBioLineRx, Ltd. · Healthy SubjectsCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2016ActualPhase 2NCT01838395Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML PatientsBioLineRx, Ltd. · Acute Myeloid LeukemiaCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2020ActualPhase 1/Phase 2NCT03154827Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)BioLineRx, Ltd. · Acute Myeloid LeukemiaTerminatedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 6, 2022ActualPhase 2NCT02826486Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer PatientsBioLineRx, Ltd. · Metastatic Pancreatic AdenocarcinomaCompletedBLRXLeadMRKCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2020ActualPhase 2NCT02462252Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult...BioLineRx, Ltd. · Aplastic AnemiaCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2014ActualPhase 1/Phase 2NCT01990885Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.BioLineRx, Ltd. · Celiac DiseaseCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2015ActualPhase 1NCT02073019A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy VolunteersBioLineRx, Ltd. · Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)CompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2013ActualPhase 2/Phase 3NCT01363349Phase IIb-III Study of BL-1020 Small Molecule for SchizophreniaBioLineRx, Ltd. · SchizophreniaTerminatedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2014ActualPhase 1/Phase 2NCT01833845Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in...BioLineRx, Ltd. · Hepatitis CTerminatedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2013ActualPhase 2NCT01506362Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative ColitisBioLineRx, Ltd. · Ulcerative ColitisCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2011ActualPhase 1NCT01121380A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021BioLineRx, Ltd. · HealthyTerminatedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2010ActualPhase 1/Phase 2NCT00557531Safety and Feasibility of the Injectable BL-1040 ImplantBioLineRx, Ltd. · Cardiovascular DiseaseUnknown statusBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2009ActualPhase 2NCT00722176Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020BioLineRx, Ltd. · SchizophreniaCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2009ActualPhase 2NCT00567710A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II StudyBioLineRx, Ltd. · SchizophreniaCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2007ActualPhase 2NCT00480571Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective DisorderBioLineRx, Ltd. · SchizophreniaCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00480246A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single...BioLineRx, Ltd. · HealthyCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2007ActualPhase 1/Phase 2NCT00374881A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human SubjectsBioLineRx, Ltd. · Acute PainCompletedBLRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 9, 2025ActualPhase 1/Phase 2NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or...Hoffmann-La Roche · Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaTerminatedBLRXCollaboratorHALOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 23, 2025ActualPhase 1NCT06547112A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide +...Washington University School of Medicine · Multiple MyelomaCompletedBLRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 24, 2025ActualPhase 1NCT05618301Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)Washington University School of Medicine · Sickle Cell DiseaseCompletedBLRXCollaboratorBIIBCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 12, 2018ActualPhase 2NCT02639559Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With...Washington University School of Medicine · Acute Myelogenous LeukemiaCompletedBLRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2018Sponsor estimatePhase 2NCT02502968BL-8040 Addition to Consolidation Therapy in AML PatientsDr. Petra Tschanter · Acute Myeloid LeukemiaUnknown statusBLRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 23 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner